Drug Shortage Report for TARO-ROSUVASTATIN
| Report ID | 21961 |
| Drug Identification Number | 02382679 |
| Brand name | RAN-ROSUVASTATIN |
| Common or Proper name | RAN-ROSUVASTATIN |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-11-28 |
| Actual start date | 2018-11-28 |
| Estimated end date | 2018-12-31 |
| Actual end date | 2017-10-31 |
| Shortage status | Avoided shortage |
| Updated date | 2019-02-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-09-12 | French | Compare |
| v1 | 2017-09-12 | English | Compare |